HB1154--ALTERNATIVETHERAPIES
SPONSOR: Houx
ThisbillrequirestheDepartmentofHealthandSeniorServices,in
collaborationwithaMissouriuniversityhospitalandmedical
centeroperatedbytheDepartmentofVeteransAffairsinMissouri,
toconductastudyontheefficacyofusingalternativemedicines
andtherapies,including,butnotlimitedto,theuseof3,4-
methylenedioxymethamphetamine (MDMA),psilocybin,andketamine,for
thetreatmentofpatientssufferingfrompost-traumaticstress
disorder,treatment-resistantdepression,substanceabuse
disorders,orwhorequireend-of-lifecare.
Thebillspecifiesthatsuchstudyshallincludeaclinicaltrial
ofpsilocybin,aswellasaliteraturereviewandthesubmissionof
variousreports. Nopersonparticipatingintheclinicaltrial
shallbesubjectedtocriminalorcivilliabilityorsanctionfor
theparticipationintheclinicaltrial,exceptincasesofgross
negligenceorwillfulmisconduct.
TheDepartmentofHealthandSeniorServicesshallprepareand
submittotheGovernor,LieutenantGovernorandtheGeneral
Assembly:
(1)Quarterlyreportsontheprogressofthestudy;and
(2)Awrittenreport,submittedoneyearafterthestudybegins,
containingtheresultsofthestudyandanyrecommendations for
legislation.
TheDepartmentshallmaintaintheconfidentiality ofanypersonally
identifiableprotectedinformationcollectedduringtheclinical
trial.
ThisbillissimilartoSB614(2023).